Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Scambia

Showing results (171-180 of 551) with videos related to

Pageof 56
Sort By:
Oncology|January 11, 2001
Topotecan and gemcitabine in platinum/paclitaxel-resistant ovarian cancerS Greggi, M G Salerno, G D'Agostino, et al.
Gynecologic Oncology|June 10, 2014
Secondary cytoreductive surgery in patients with isolated platinum-resistant recurrent ovarian cancer: a retrospective analysisM Petrillo, L Pedone Anchora, L Tortorella, et al.
Cancer|March 1, 1991
Receptors for epidermal growth factor and steroid hormones in primary laryngeal tumorsG Scambia, P B Panici, F Battaglia, et al.
Oncology|January 1, 1988
Receptors for epidermal growth factor and steroid hormones in human breast cancerF Battaglia, G Polizzi, G Scambia, et al.
European Journal of Gynaecological Oncology|January 1, 1990
Monitoring ovarian cancer using urine cyclic GMP. A two-centre studyG A Turner, S Greggi, D Guthrie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
nm23 in ovarian cancer: correlation with clinical outcome and other clinicopathologic and biochemical prognostic parametersG Scambia, G Ferrandina, M Marone, et al.
Leukemia|February 13, 2002
Transforming growth factor-beta1 transcriptionally activates CD34 and prevents induced differentiation of TF-1 cells in the absence of any cell-cycle effectsM Marone, G Scambia, G Bonanno, et al.
International Journal of Cancer|August 22, 1997
Altered expression of cyclin D1 and CDK4 genes in ovarian carcinomasV Masciullo, G Scambia, M Marone, et al.
Annals of Surgical Oncology|December 31, 2015
Long-Term Survival for Platinum-Sensitive Recurrent Ovarian Cancer Patients Treated with Secondary Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC)M Petrillo, P De Iaco, S Cianci, et al.
International Journal of Cancer|January 14, 1998
Analysis of cyclin E and CDK2 in ovarian cancer: gene amplification and RNA overexpressionM Marone, G Scambia, C Giannitelli, et al.
Pageof 56

Showing results (171-180 of 551) with videos related to

Sort By:
Pageof 56
Oncology|January 11, 2001
Topotecan and gemcitabine in platinum/paclitaxel-resistant ovarian cancerS Greggi, M G Salerno, G D'Agostino, et al.
Gynecologic Oncology|June 10, 2014
Secondary cytoreductive surgery in patients with isolated platinum-resistant recurrent ovarian cancer: a retrospective analysisM Petrillo, L Pedone Anchora, L Tortorella, et al.
Cancer|March 1, 1991
Receptors for epidermal growth factor and steroid hormones in primary laryngeal tumorsG Scambia, P B Panici, F Battaglia, et al.
Oncology|January 1, 1988
Receptors for epidermal growth factor and steroid hormones in human breast cancerF Battaglia, G Polizzi, G Scambia, et al.
European Journal of Gynaecological Oncology|January 1, 1990
Monitoring ovarian cancer using urine cyclic GMP. A two-centre studyG A Turner, S Greggi, D Guthrie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
nm23 in ovarian cancer: correlation with clinical outcome and other clinicopathologic and biochemical prognostic parametersG Scambia, G Ferrandina, M Marone, et al.
Leukemia|February 13, 2002
Transforming growth factor-beta1 transcriptionally activates CD34 and prevents induced differentiation of TF-1 cells in the absence of any cell-cycle effectsM Marone, G Scambia, G Bonanno, et al.
International Journal of Cancer|August 22, 1997
Altered expression of cyclin D1 and CDK4 genes in ovarian carcinomasV Masciullo, G Scambia, M Marone, et al.
Annals of Surgical Oncology|December 31, 2015
Long-Term Survival for Platinum-Sensitive Recurrent Ovarian Cancer Patients Treated with Secondary Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC)M Petrillo, P De Iaco, S Cianci, et al.
International Journal of Cancer|January 14, 1998
Analysis of cyclin E and CDK2 in ovarian cancer: gene amplification and RNA overexpressionM Marone, G Scambia, C Giannitelli, et al.
Pageof 56